Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt

Breast Cancer Res Treat. 2010 Feb;120(1):149-60. doi: 10.1007/s10549-009-0427-9. Epub 2009 Jun 23.

Abstract

Breast cancer incidence is higher in developed countries with higher rates of estrogen receptor positive (ER+) tumors. ER+ tumors are caused by estrogenic exposures although known exposures explain approximately 50% of breast cancer risk. Unknown risk factors causing high breast cancer incidence exist that are estrogenic and development-related. Xenoestrogens are such risk factors but are difficult to study since developed countries lack unexposed populations. Developing countries have urban-rural populations with differential exposure to xenoestrogens. This study assessed urban-rural breast cancer incidence classified by hormone receptor status using data from Gharbiah population-based cancer registry in Egypt from 2001 to 2006. Urban ER+ incidence rate (per 100,000 women) was 2-4 times (IRR = 3.36, 95% CI = 4.84, 2.34) higher than rural incidence rate. ER-incidence rate was 2-3 times (IRR = 1.86, 95% CI = 2.38, 1.45) higher in urban areas than in rural areas. Our findings indicate that urban women may probably have a higher exposure to xenoestrogens.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Breast Neoplasms / epidemiology*
  • Breast Neoplasms / pathology
  • Child
  • Child, Preschool
  • Egypt / epidemiology
  • Female
  • Humans
  • Immunohistochemistry
  • Incidence
  • Infant
  • Infant, Newborn
  • Middle Aged
  • Neoplasm Staging
  • Neoplasms, Hormone-Dependent / epidemiology*
  • Neoplasms, Hormone-Dependent / pathology
  • Receptors, Estrogen / metabolism*
  • Receptors, Progesterone / metabolism
  • Registries
  • Rural Population / statistics & numerical data*
  • Urban Population / statistics & numerical data*
  • Young Adult

Substances

  • Receptors, Estrogen
  • Receptors, Progesterone